TY - JOUR AU - Thurman, Angela John AU - Potter, Laura A. AU - Kim, Kyoungmi AU - Tassone, Flora AU - Banasik, Amy AU - Potter, Sarah Nelson AU - Bullard, Lauren AU - Nguyen, Vivian AU - McDuffie, Andrea AU - Hagerman, Randi AU - Abbeduto, Leonard PY - 2020 DA - 2020/04/22 TI - Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome JO - Journal of Neurodevelopmental Disorders SP - 12 VL - 12 IS - 1 AB - The purpose of this study was to conduct a 20-week controlled trial of lovastatin (10 to 40 mg/day) in youth with fragile X syndrome (FXS) ages 10 to 17 years, combined with an open-label treatment of a parent-implemented language intervention (PILI), delivered via distance video teleconferencing to both treatment groups, lovastatin and placebo. SN - 1866-1955 UR - https://doi.org/10.1186/s11689-020-09315-4 DO - 10.1186/s11689-020-09315-4 ID - Thurman2020 ER -